Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors.

E. Diaz-Rubio; T.R.J. Evans; J. Taberno; J. Cassidy; J. Sastre; Martin Eatock; D. Bisset; P. Regueiro; J. Baselga

doi:10.1093/annonc/mdf065

Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors.

E. Diaz-Rubio, T.R.J. Evans, J. Taberno, J. Cassidy, J. Sastre, Martin Eatock, D. Bisset, P. Regueiro, J. Baselga

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to journal › Article › peer-review

104 Citations (Scopus)

Original language	English
Pages (from-to)	558-565
Number of pages	8
Journal	Annals of Oncology
Volume	13(4)
Issue number	4
DOIs	https://doi.org/10.1093/annonc/mdf065
Publication status	Published - Jan 2002

ASJC Scopus subject areas

Cancer Research
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdf065

Cite this

@article{d19b8e06e8bd4af38370581d4bf500ba,

title = "Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors.",

author = "E. Diaz-Rubio and T.R.J. Evans and J. Taberno and J. Cassidy and J. Sastre and Martin Eatock and D. Bisset and P. Regueiro and J. Baselga",

year = "2002",

month = jan,

doi = "10.1093/annonc/mdf065",

language = "English",

volume = "13(4)",

pages = "558--565",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors.

AU - Diaz-Rubio, E.

AU - Evans, T.R.J.

AU - Taberno, J.

AU - Cassidy, J.

AU - Sastre, J.

AU - Eatock, Martin

AU - Bisset, D.

AU - Regueiro, P.

AU - Baselga, J.

PY - 2002/1

Y1 - 2002/1

UR - http://www.scopus.com/inward/record.url?scp=0035987216&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdf065

DO - 10.1093/annonc/mdf065

M3 - Article

C2 - 12056706

SN - 0923-7534

VL - 13(4)

SP - 558

EP - 565

JO - Annals of Oncology

JF - Annals of Oncology

IS - 4

ER -

Capecitabine (Xeloda) in combination with oxaliplatin: a phase I, dose-escalation study in patients with advanced or metastatic solid tumors.

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this